Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma

Fig. 1

Magnetic resonance imaging scan of a 69-year-old patient with liver cirrhosis and hepatocellular carcinoma in liver segment III (a, arrow). The tumor was treated by CT-guided high-dose rate brachytherapy with a single catheter and a tumor-enclosing target dose of 20 Gy (b). Six weeks later, complete tumor ablation is indicated by a surrounding lack of uptake of hepatocyte-specific contrast medium (Primovist™, Bayer Healthcare, Leverkusen, Germany) (c, arrow)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us